Protein iron succinate

Iron proteinsuccinylate CAS 93615-44-2 Protein succinate iron oral solution is indicated for the treatment of implicit or explicit iron deficiency anemia caused by insufficient iron intake or absorption disorders, acute or chronic blood loss, and infection, as well as absolute and relative iron deficiency anemia such as pregnancy and lactation anemia.

Send To Us

Sonraí Táirge

Clibeanna Táirge

Protein iron succinate

CAS 93615-44-2

Iron proteinsuccinylate

Protein succinate iron oral solution is indicated for the treatment of implicit or explicit iron deficiency anemia caused by insufficient iron intake or absorption disorders, acute or chronic blood loss, and infection, as well as absolute and relative iron deficiency anemia such as pregnancy and lactation anemia.

Léigh Ár Nuacht is Déanaí

Jul.03，2025

The Effect of 6-Amino-1,3-dimethyl-5-nitrosouracil on the Release Rate of Caffeine Rapid Release Products

Pharmaceutical intermediates play a crucial role in the synthesis and optimization of active pharmaceutical ingredients (APIs).

Leigh Nios mo

Jul.03，2025

Technological Advantages of Using 6-Amino-1,3-dimethyluracil for Low-Temperature Caffeine Synthesis

The pharmaceutical industry is constantly seeking innovative approaches to optimize synthetic pathways for active pharmaceutical ingredients (APIs).

Leigh Nios mo

Jul.03，2025

Performance Analysis of 1,3-Dimethylurea Resin Generated by Reaction with Formaldehyde

1,3-Dimethylurea (CAS No. 96-31-1) is an organic compound widely used as a pharmaceutical intermediate and in specialty chemical applications.

Leigh Nios mo